Back to Group One Trading LLC Group One Trading LLC

AXSMAXSM

Showing 8 of 31 quarters

Position history for Group One Trading LLCGroup One Trading LLC's holdings in Axsome Therapeutics, Inc.

No. Group One Trading exited its AXSM (Axsome Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 214 shares worth $36,170. Group One Trading already held AXSM in its Q4 2018 13F, the earliest on record, and held it in 28 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$4.5M

Total Shares Change

-50,141

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$244.77
0
2026-Q1
Decreased
214
-99.0%
$36,1700.0%$169.02
0
2025-Q4
Decreased
22,211
-29.9%
$4.1M0.0%$182.64
0
2025-Q3
Decreased
31,703
-13.2%
$3.9M0.0%$121.45
0
2025-Q2
Increased
36,528
+43.1%
$3.8M0.0%$104.39
36
2025-Q1
Decreased
25,523
-41.8%
$3M0.0%$116.63
0
2024-Q4
Decreased
43,820
-12.6%
$3.7M0.0%$84.61
0
2024-Q3
New
50,141
—
$4.5M0.0%$89.87
37

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used